Erlizumab (Anti-Integrin b2 / ITGB2 / CD18)
A2712
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameErlizumab (Anti-Integrin b2 / ITGB2 / CD18)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionErlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.
- Storage Instruction-20°C
- UNSPSC12352203